Sirtuin Inhibitor as a Novel Cell Cycle Checkpoint and Regulator of the TP53-MDM2 Pathway in Uveal MelanomaZachary K. Goldsmith, Vanessa Morales-Tirado|The Ophthalmology - Open Journal|2019Cited by 1